Symptom prevalence and functional status in patient with terminal phase of head and neck cancer

DOI Web Site 14 References
  • Hirakawa Hitoshi
    Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus Department of Head and Neck Surgery, Aichi Cancer Center Hospital
  • Shinozaki Takeshi
    Department of Head and Neck Surgery, National Cancer Center Hospital East
  • Ebihara Mitsuru
    Ebihara Clinic
  • Shimbashi Wataru
    Division of Head and Neck Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research
  • Kamijo Tomoyuki
    Department of Head and Neck Surgery, Shizuoka Cancer Center
  • Okamoto Makito
    Department of Otolaryngology, Head and Neck Surgery, Kitasato University School of Medicine
  • Beppu Takeshi
    Department of Head and Neck Surgery, Saitama Cancer Center
  • Ohori Junichiro
    Department of Otolaryngology, Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences
  • Matsuura Kazuto
    Division of Head and Neck Surgery, Miyagi Cancer Center
  • Suzuki Motoyuki
    Department of Head and Neck Surgery, Osaka International Cancer Institute
  • Nishino Hiroshi
    Department of Otolaryngology, Head and Neck Surgery, Jichi Medical University
  • Sato Yuichiro
    Department of Head and Neck Surgery, Niigata Cancer Center Hospital
  • Ishiki Hiroto
    Department of Palliative Medicine, National Cancer Center Hospital

Bibliographic Information

Other Title
  • 頭頸部癌患者の終末期における諸症状と機能に関する研究
  • —多施設共同研究—
  • : multi-institutional research

Search this article

Description

There have been a limited number of studies about clinical symptoms in patients in the terminal phase of head and neck cancers. The aim of this prospective multi-institutional study （11 institutes） was to assess the prevalence of symptoms and functional status among patients with advanced head and neck cancer. Of the 100 patients who met the inclusion criteria, 72 patients were observed until their death. Neck dressing treatment was needed for skin-infiltration symptoms, such as bleeding, infection, and exudation in 30.6% of patients at study entry and in 36.1% just before death. Severe bleeding causing death was observed in 6.9% of patients and the lethal rupture of the carotid artery was seen in only one case （1.4%）. At the time of study entry, 75% of patients maintained enteral nutrition, and 61.1% still received enteral nutrition just before death. Laryngeal phonation ability was not maintained in 44.4% of patients at the time of study entry and 50% just before death. Edema in the head and neck region was observed in 23.6% of patients at entry and 36.1% at the time of death. Since the above-mentioned symptoms in patients in the terminal phase were not mild, these symptoms sometimes cause uneasiness in head and neck patients, their families, and the medical staff. <br>To relieve the anxiety of patients, families, and the medical staff, further large-scale prospective studies are needed to establish care management of head and neck cancer patients in the terminal phase and bring them a better quality of life in the terminal phase.

Journal

  • Toukeibu Gan

    Toukeibu Gan 44 (1), 75-81, 2018

    Japan Society for Head and Neck Cancer

References(14)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top